"Pseudomonas aeruginosa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
| Descriptor ID |
D011550
|
| MeSH Number(s) |
B03.440.400.425.625.625.100 B03.660.250.580.590.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pseudomonas aeruginosa".
Below are MeSH descriptors whose meaning is more specific than "Pseudomonas aeruginosa".
This graph shows the total number of publications written about "Pseudomonas aeruginosa" by people in this website by year, and whether "Pseudomonas aeruginosa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 3 | 4 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 2 | 0 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2014 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 3 | 4 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 1 | 3 |
| 2020 | 3 | 1 | 4 |
| 2021 | 3 | 1 | 4 |
| 2022 | 2 | 2 | 4 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pseudomonas aeruginosa" by people in Profiles.
-
Inhibitor of Chromosome Segregation in Pseudomonas aeruginosa from Fungal Extracts. ACS Chem Biol. 2024 Jun 21; 19(6):1387-1396.
-
Novel antimony-based antimicrobial drug targets membranes of Gram-positive and Gram-negative bacterial pathogens. Microbiol Spectr. 2024 Jun 04; 12(6):e0423423.
-
Pseudomonas aeruginosa pulmonary infection results in S100A8/A9-dependent cardiac dysfunction. PLoS Pathog. 2023 08; 19(8):e1011573.
-
Functional Diversity of Gram-Negative Permeability Barriers Reflected in Antibacterial Activities and Intracellular Accumulation of Antibiotics. Antimicrob Agents Chemother. 2023 02 16; 67(2):e0137722.
-
Making sense of drug-efflux transporters in the physiological environment. Curr Opin Microbiol. 2022 10; 69:102179.
-
Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia. Intensive Care Med. 2022 07; 48(7):963-964.
-
Property space mapping of Pseudomonas aeruginosa permeability to small molecules. Sci Rep. 2022 05 17; 12(1):8220.
-
Condensins are essential for Pseudomonas aeruginosa corneal virulence through their control of lifestyle and virulence programs. Mol Microbiol. 2022 04; 117(4):937-957.
-
ParD Antitoxin Hotspot Alters a Disorder-to-Order Transition upon Binding to Its Cognate ParE Toxin, Lessening Its Interaction Affinity and Increasing Its Protease Degradation Kinetics. Biochemistry. 2022 01 04; 61(1):34-45.
-
Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms. Antimicrob Agents Chemother. 2021 10 18; 65(11):e0084621.